Operating Income Summary of PhytoHealth Corporation

PhytoHealth Corporation's latest annual operating income in 2023 was -121.67 Million TWD , down -6.3% from previous year.
PhytoHealth Corporation's latest quarterly operating income in 2024 Q2 was -30.42 Million TWD , up 33.64% from previous quarter.
PhytoHealth Corporation reported an annual operating income of -114.46 Million TWD in 2022, down -20.22% from previous year.
PhytoHealth Corporation reported an annual operating income of -95.21 Million TWD in 2021, up 17.87% from previous year.
PhytoHealth Corporation reported a quarterly operating income of -30.42 Million TWD for 2024 Q2, up 33.64% from previous quarter.
PhytoHealth Corporation reported a quarterly operating income of -54.31 Million TWD for 2024 Q3, down -78.51% from previous quarter.

Annual Operating Income Chart of PhytoHealth Corporation (2023 - 2009)

Historical Annual Operating Income of PhytoHealth Corporation (2023 - 2009)

Year	Operating Income	Operating Income Growth
2023	-121.67 Million TWD	-6.3%
2022	-114.46 Million TWD	-20.22%
2021	-95.21 Million TWD	17.87%
2020	-115.92 Million TWD	43.34%
2019	-204.59 Million TWD	23.9%
2018	-268.83 Million TWD	-0.18%
2017	-268.35 Million TWD	-12.17%
2016	-239.23 Million TWD	10.22%
2015	-266.45 Million TWD	22.92%
2014	-345.7 Million TWD	-43.83%
2013	-240.35 Million TWD	-74.5%
2012	-137.74 Million TWD	28.79%
2011	-193.43 Million TWD	11.54%
2010	-218.67 Million TWD	10.22%
2009	-243.58 Million TWD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	-45.85 Million TWD	-8.53%
2024 Q2	-30.42 Million TWD	33.64%
2024 Q3	-54.31 Million TWD	-78.51%
2023 Q3	-476 Thousand TWD	97.88%
2023 Q4	-42.24 Million TWD	-8775.84%
2023 FY	-121.67 Million TWD	-6.3%
2023 Q1	-15.81 Million TWD	68.11%
2023 Q2	-22.4 Million TWD	-41.73%
2022 Q2	-25.76 Million TWD	24.49%
2022 Q3	-5 Million TWD	80.59%
2022 Q4	-49.57 Million TWD	-891.58%
2022 Q1	-34.11 Million TWD	-4.32%
2022 FY	-114.46 Million TWD	-20.22%
2021 Q2	-36.83 Million TWD	2.0%
2021 Q4	-32.7 Million TWD	-99.87%
2021 FY	-95.21 Million TWD	17.87%
2021 Q1	-37.58 Million TWD	-22.07%
2021 Q3	-16.36 Million TWD	55.58%
2020 Q3	-45.69 Million TWD	-5.35%
2020 Q2	-43.37 Million TWD	14.09%
2020 Q1	-50.48 Million TWD	47.68%
2020 Q4	-30.79 Million TWD	32.61%
2020 FY	-115.92 Million TWD	43.34%
2019 Q3	-55.74 Million TWD	-43.87%
2019 FY	-204.59 Million TWD	23.9%
2019 Q1	-44.86 Million TWD	54.92%
2019 Q2	-38.74 Million TWD	13.63%
2019 Q4	-96.49 Million TWD	-73.11%
2018 Q2	-57.78 Million TWD	-6.87%
2018 FY	-268.83 Million TWD	-0.18%
2018 Q4	-99.5 Million TWD	-73.17%
2018 Q3	-57.46 Million TWD	0.56%
2018 Q1	-54.07 Million TWD	49.48%
2017 Q3	-59.33 Million TWD	-22.2%
2017 FY	-268.35 Million TWD	-12.17%
2017 Q2	-48.55 Million TWD	9.1%
2017 Q4	-107.04 Million TWD	-80.4%
2017 Q1	-53.42 Million TWD	6.6%
2016 Q1	-67.05 Million TWD	-34.92%
2016 FY	-239.23 Million TWD	10.22%
2016 Q3	-51.09 Million TWD	20.02%
2016 Q4	-57.19 Million TWD	-11.94%
2016 Q2	-63.88 Million TWD	4.74%
2015 Q1	-84.97 Million TWD	21.39%
2015 Q2	-72.41 Million TWD	14.78%
2015 Q3	-59.36 Million TWD	18.01%
2015 Q4	-49.7 Million TWD	16.28%
2015 FY	-266.45 Million TWD	22.92%
2014 Q4	-108.09 Million TWD	-50.53%
2014 Q2	-122.85 Million TWD	-186.09%
2014 FY	-345.7 Million TWD	-43.83%
2014 Q1	-42.94 Million TWD	61.64%
2014 Q3	-71.81 Million TWD	41.55%
2013 Q3	-55.7 Million TWD	-61.75%
2013 Q1	-38.28 Million TWD	-3.28%
2013 FY	-240.35 Million TWD	-74.5%
2013 Q4	-111.92 Million TWD	-100.93%
2013 Q2	-34.43 Million TWD	10.04%
2012 Q3	-43.38 Million TWD	-56.92%
2012 Q2	-27.64 Million TWD	6.76%
2012 Q1	-29.64 Million TWD	46.83%
2012 Q4	-37.06 Million TWD	14.56%
2012 FY	-137.74 Million TWD	28.79%
2011 Q1	-47.36 Million TWD	45.16%
2011 FY	-193.43 Million TWD	11.54%
2011 Q4	-55.75 Million TWD	-2.08%
2011 Q3	-54.62 Million TWD	-53.03%
2011 Q2	-35.69 Million TWD	24.64%
2010 FY	-218.67 Million TWD	10.22%
2010 Q4	-86.36 Million TWD	-70.41%
2010 Q1	-37.69 Million TWD	0.0%
2010 Q2	-43.93 Million TWD	-16.54%
2010 Q3	-50.68 Million TWD	-15.35%
2009 FY	-243.58 Million TWD	0.0%

Peer Operating Income Comparison of PhytoHealth Corporation

Name	Operating Income	Operating Income Difference
Grape King Bio Ltd	2.49 Billion TWD	104.874%
Standard Chem & Pharm CO., LTD.	1.25 Billion TWD	109.66%
Maywufa Company Ltd.	211.01 Million TWD	157.662%
ScinoPharm Taiwan, Ltd.	314.49 Million TWD	138.69%
Lotus Pharmaceutical Co., Ltd.	4.9 Billion TWD	102.482%
LIWANLI Innovation Co., Ltd.	- TWD	Infinity%
YungShin Global Holding Corporation	929.61 Million TWD	113.089%
SCI Pharmtech, Inc.	160.3 Million TWD	175.906%
Formosa Laboratories, Inc.	674.97 Million TWD	118.027%
PharmaEssentia Corporation	- TWD	Infinity%
Bora Pharmaceuticals Co., LTD.	5.24 Billion TWD	102.318%

Global Stocks Search

PhytoHealth Corporation (4108.TW)

Operating Income Summary of PhytoHealth Corporation

Annual Operating Income Chart of PhytoHealth Corporation (2023 - 2009)

Historical Annual Operating Income of PhytoHealth Corporation (2023 - 2009)

Peer Operating Income Comparison of PhytoHealth Corporation